v3.25.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balances, at Beginning of period at Dec. 31, 2023 $ 1,040 $ 406,925 $ (175,798) $ 232,167
Balances, at Beginning of period, Shares at Dec. 31, 2023 103,961,670      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense   3,015   3,015
Vesting of restricted stock units $ 1 (1)    
Vesting of restricted stock units, shares 170,801      
Exercise of stock options $ 3 700   703
Exercise of stock options, shares 272,640      
Net loss     (9,526) (9,526)
Balances, at end of period at Mar. 31, 2024 $ 1,044 410,639 (185,324) 226,359
Balances, at end of period, Shares at Mar. 31, 2024 104,405,111      
Balances, at Beginning of period at Dec. 31, 2024 $ 1,057 422,047 (216,853) 206,251
Balances, at Beginning of period, Shares at Dec. 31, 2024 105,711,093      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense   3,039   3,039
Vesting of restricted stock units $ 3 (3)    
Vesting of restricted stock units, shares 311,632      
Exercise of stock options $ 3 380   383
Exercise of stock options, shares 290,993      
Net loss     (10,261) (10,261)
Balances, at end of period at Mar. 31, 2025 $ 1,063 $ 425,463 $ (227,114) $ 199,412
Balances, at end of period, Shares at Mar. 31, 2025 106,313,718